Jeong Hwan Kim (Jeong-Hwan Kim)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Polycyclic Aromatic Hydrocarbons

Advanced Non Small Cell Lung Cancer

Prognostic Factors

Top Venues

Cancer research

Scientific reports

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ye Jin Ha, Seong-Hwan Park, Ka Hee Tak, Jong Lyul Lee, Chan Wook Kim, Jeong Hwan Kim, Seon-Young Kim, Seon-Kyu Kim, Yong Sik Yoon
CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer. Scientific reports 14 (1) (2024)
Seung-Jin Park, Shinyeong Ju, Sung-Ho Goh, Byoung-Ha Yoon, Jong-Lyul Park, Jeong Hwan Kim, Seonjeong Lee, Sang-Jin Lee, Yumi Kwon, Wonyeop Lee, Kyung Chan Park, Geon Kook Lee, Seog Yun Park, Sunshin Kim, Seon-Young Kim, Ji-Youn Han, Cheolju Lee
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations. Cancer research 84 (9) (2024)
Seung-Jin Park, Shinyeong Ju, Sung-Ho Goh, Byoung-Ha Yoon, Jong-Lyul Park, Jeong Hwan Kim, Seonjeong Lee, Sang-Jin Lee, Yumi Kwon, Wonyeop Lee, Kyung Chan Park, Geon Kook Lee, Seog Yun Park, Sunshin Kim, Seon-Young Kim, Ji-Youn Han, Cheolju Lee
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations. Cancer research 84 (9) (2024)
Ye Jin Ha, Seong-Hwan Park, Ka Hee Tak, Jong Lyul Lee, Chan Wook Kim, Jeong Hwan Kim, Seon-Young Kim, Seon-Kyu Kim, Yong Sik Yoon
CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer. Scientific reports 14 (1) (2024)
Seung-Jin Park, Shinyeong Ju, Sung-Ho Goh, Byoung-Ha Yoon, Jong-Lyul Park, Jeong Hwan Kim, Seonjeong Lee, Sang-Jin Lee, Yumi Kwon, Wonyeop Lee, Kyung Chan Park, Geon Kook Lee, Seog Yun Park, Sunshin Kim, Seon-Young Kim, Ji-Youn Han, Cheolju Lee
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations. Cancer research (2024)
Ye Jin Ha, Seong-Hwan Park, Ka Hee Tak, Jong Lyul Lee, Chan Wook Kim, Jeong Hwan Kim, Seon-Young Kim, Seon-Kyu Kim, Yong Sik Yoon
CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer. Scientific reports 14 (1) (2024)
Ye Jin Ha, Yun Jae Shin, Ka Hee Tak, Jong-Lyul Park, Jeong Hwan Kim, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, Seon-Young Kim, Jin Cheon Kim
Reduced expression of alanyl aminopeptidase is a robust biomarker of non-familial adenomatous polyposis and non-hereditary nonpolyposis colorectal cancer syndrome early-onset colorectal cancer. Cancer medicine (2023)